Tomi Environmental Solutions I Stock Price, News & Analysis

TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) reported its financial results for Q4 and full year 2022, showcasing growth in revenue and a significant reduction in losses. Total net revenue for Q4 was $2.81 million, an increase of 40% year-over-year, while annual revenue rose by 8% to $8.34 million. Notably, the net loss shrank by 58% to $2.88 million, with an adjusted EBITDA loss of $1.90 million. The company attributes this growth to increased demand for its CES systems and mobile equipment, with a recognized revenue and backlog of $10.4 million. Additionally, TOMI has seen a robust sales pipeline, receiving over $10 million in orders from global clients.

TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) will report its fourth-quarter results for the period ending December 31, 2022, on March 16, 2023, post-market. A conference call will follow at 4:30 p.m. ET. Investors can participate by calling 877-545-0523 (international: 973-528-0016) and using access code 105041. A replay will be available until March 30, 2023. TOMI specializes in disinfection solutions through its patented Binary Ionization Technology (BIT™), primarily used in various sectors including healthcare, pharmaceuticals, and food processing.

TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) announced its participation in three upcoming ISPE Conferences in early 2023, showcasing its SteraMist disinfection products. The events include the ISPE Facilities of the Future Conference in Bethesda, MD (January 31-February 1), the ISPE-CaSA Life Sciences Technology Conference in Raleigh, NC (February 28), and the ISPE Aseptic Conference back in Bethesda, MD (March 6-7). These conferences serve as a platform for TOMI to highlight its advanced decontamination technologies to a wide audience within the pharmaceutical engineering sector, reinforcing its commitment to innovation in the life sciences market.

TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) has announced that NHS Wales has purchased their SteraMist ionized Hydrogen Peroxide (iHP) technology, marking a significant step in expanding their footprint in Great Britain. The NHS Wales aims to enhance its aseptic pharmaceutical manufacturing capabilities, finding traditional cleaning methods cumbersome for large facilities. The purchase includes a SteraMist Environment System, which NHS Wales reported will improve the quality of medicines supplied to patients. TOMI continues to grow its international partnerships, with purchases from various countries, making its SteraMist solutions accessible globally.

TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) reported its financial results for Q3 and nine months ending September 30, 2022. Customer sales orders grew by 25% year-over-year, reaching $7.9 million. Despite a sequential revenue drop to $1.76 million, gross margin improved to 60.9%. The operating loss decreased by 24% compared to Q2 2022, reflecting a reduction in operating expenses by 16%. The company anticipates converting a backlog of $2.66 million into revenue. CEO Dr. Halden Shane emphasized a robust sales pipeline heading into 2023.

TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) announced it will release its third-quarter results on November 10, 2022, after market close, followed by a conference call at 4:30 p.m. ET. Participants can join the call via a dedicated phone line or through a live webcast, accessible on the company's investor relations page. A replay will be available until November 24, 2022. TOMI specializes in disinfection technologies, particularly its Binary Ionization Technology (BIT™), aimed at diverse sectors including healthcare and food processing.

TOMI Environmental Solutions (NASDAQ: TOMZ) has announced the purchase of SteraMist disinfection systems by the U.S. Department of Health and Human Services for its Biosafety Level 3 laboratory in Africa. This order includes two SteraPak systems and two Select Surface Units, expanding the NIH's deployment of SteraMist to 30 machines across 11 divisions. SteraMist's technology features a low concentration of hydrogen peroxide, enabling effective disinfection while minimizing equipment corrosion. The COO stated their commitment to supporting NIH's mission with innovative solutions.

TOMI Environmental Solutions (NASDAQ: TOMZ) announced a significant $280,000 purchase order from Critical Scientific Solutions for three modified SteraMist Environment Systems. These systems will be utilized by a leading influenza vaccine company for decontamination of cleanrooms and ductwork. The partnership has proven effective since its inception, gaining traction in Australia and New Zealand. TOMI's COO expressed optimism regarding future opportunities in the Life Science sector, emphasizing strong demand for their custom engineered systems.

TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) has received a purchase order for an iHP Custom Engineered System from Avid Bioservices for a new viral vector manufacturing facility in Costa Mesa, California. This system will be implemented in four GMP manufacturing suites and will include eleven applicators. SteraMist was selected due to its rapid decontamination capabilities and low hydrogen peroxide content. The installation is expected to be completed in the first half of 2023, marking a significant step in TOMI's collaboration with Avid, emphasizing the effectiveness of SteraMist technology in the growing cell and gene therapy market.